By the age of thirty, a woman’s fertility starts to slow and complications increase the chance of complications in pregnancy. It is true that women who get pregnant in their late 30’s and early 40’s are more prone to diabetes, high blood pressure and increased genetic abnormalities. However, the results of a study that observed women who gave birth after the age of 40 found they had a 44 percent reduction on the rate of endometrial cancer compared to women who gave birth before age 25. Even those giving birth later than the age of 40 showed a 33 percent reduction than those who had babies before 25. The study, led by, assistant professor of preventive medicine V. Wendy Setiawan of the University of Southern California, was published in The American Journal of Epidemiology in July of this year.

Some exciting and breathtaking news has finally been released recently regarding cancerous and untreatable tumors. It has been announced that some of the untreatable cancers out there can soon be held in its place by a brand new experimental drug that will target not only the tumor, but how it spreads throughout the body. By restricting its growth, it can help the patient in their attempt at staying healthy.
This new drug, which is called Cabozantinib, or cabo for short, will neutralize the two main mechanisms that cancers need to survive and spread. By targeting these two mechanisms, it can help the patient get healthy, when they feel they had no chance at staying healthy.